Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Retrospective Cohort Database Study to Assess the Safety of Boostrix (U.S. Formulation), a Reduced Tetanus, Diphtheria, Acellular Pertussis Vaccine (Tdap), Following Routine Immunization of Pregnant Women in the United States

NCT03463577 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03463577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03463577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Retrospective Cohort Database Study to Assess the Safety of Boostrix (U.S. Formulation), a Reduced Tetanus, Diphtheria, Acellular Pertussis Vaccine (Tdap), Following Routine Immunization of Pregnant Women in the United States
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
April 13, 2018
Completion date
August 4, 2020
Enrollment
65,783 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

whooping cough